Publications for Golo Ahlenstiel
Publications for Golo Ahlenstiel
2016
Eslam, M., Hashem, A., Romero-Gomez, M.,
Berg, T., Dore, G., Mangia, A., Chan, H., Irving,
W., Sheridan, D., Abate, M., Weltman, M.,
Ahlenstiel, G., Liddle, C., Douglas, M., Booth,
D., George, J., et al (2016). FibroGENE: A
gene-based model for staging liver fibrosis.
Journal of Hepatology, 64(2), 390-398. <a
href="http://dx.doi.org/10.1016/j.jhep.2015.11.0
08">[More Information]</a>
2015
Musumba, C., Hsu, J., Ahlenstiel, G., Tutticci,
N., Nanda, K., van der Poorten, D., Lee, E.,
Kwan, V. (2015). Feasibility and Safety of
Overtubes for PEG-Tube Placement in Patients
with Head and Neck Cancer. Gastroenterology
Research and Practice, 2015, 1-7. <a
href="http://dx.doi.org/10.1155/2015/612610">[
More Information]</a>
Eslam, M., Hashem, A., Leung, R.,
Romero-Gomez, M., Berg, T., Dore, G., Chan,
H., Irving, W., Sheridan, D., Abate, M.,
Weltman, M., Douglas, M., Liddle, C., Booth,
D., George, J., Ahlenstiel, G., et al (2015).
Interferon-λ rs12979860 genotype and liver
fibrosis in viral and non-viral chronic liver
disease. Nature Communications, 6, 1-10. <a
href="http://dx.doi.org/10.1038/ncomms7422">[
More Information]</a>
Garcia, M., Ahlenstiel, G., Mahajan, H., van der
Poorten, D. (2015). Small bowel varices
secondary to chronic superior mesenteric vein
thrombosis in a patient with heterozygous Factor
V Leiden mutation: a case report. Journal of
Medical Case Reports, 9(1), 1-4. <a
href="http://dx.doi.org/10.1186/s13256-015-070
5-6">[More Information]</a>
Dold, L., Ahlenstiel, G., Eva, A., Luda, C.,
Schwarze-Zander, C., Boesecke, C., Wasmuth,
J., Rockstroh, J., Spengler, U. (2015). Survival
and HLA-B*57 in HIV/HCV co-infected patients
on highly active antiretroviral therapy (HAART).
PloS One, 10(8), 1-13. <a
href="http://dx.doi.org/10.1371/journal.pone.013
4158">[More Information]</a>
2014
Beard, M., Ffrench, R., Gowans, E., Helbig, K.,
Eyre, N., Douglas, M., Grebely, J., Ahlenstiel,
G., Locarnini, S., George, J., et al (2014). A
Summary of the 20(th) International Symposium
on Hepatitis C Virus and Related Viruses.
Gastroenterology, 147(1), e1-e4. <a
href="http://dx.doi.org/10.1053/j.gastro.2014.05.
022">[More Information]</a>
Ahlenstiel, G., Hourigan, L., Brown, G., Zanati,
S., Williams, S., Singh, R., Moss, A., Sonson, R.,
Bourke, M. (2014). Actual endoscopic versus
predicted surgical mortality for treatment of
advanced mucosal neoplasia of the colon.
Gastrointestinal Endoscopy, 80(4), 668-676. <a
href="http://dx.doi.org/10.1016/j.gie.2014.04.01
5">[More Information]</a>
O’Day, R., Ahlenstiel, G., Chittaranjan Shetty,
A., Favaloro, E., Williams, S., Koutts, J. (2014).
Artefactual "in-vitro coagulopathy" in a patient
with non-Hodgkin lymphoma and lower
gastrointestinal bleeding. Medical Journal of
Australia, 200(5), 293-294. <a
href="http://dx.doi.org/10.5694/mja13.10921">[
More Information]</a>
O'Connor, K., George, J., Booth, D., Ahlenstiel,
G. (2014). Dendritic cells in hepatitis C virus
infection: Key players in the IFNL3-genotype
response. World Journal of Gastroenterology,
20(47), 17830-17838. <a
href="http://dx.doi.org/10.3748/wjg.v20.i47.178
30">[More Information]</a>
Rotman, Y., Noureddin, M., Feld, J., Guedj, J.,
Witthaus, M., Han, H., Park, Y., Park, S., Heller,
T., Ghany, M., Ahlenstiel, G., et al (2014). Effect
of ribavirin on viral kinetics and liver gene
expression in chronic hepatitis C. Gut (English
Edition): an international journal of
gastroenterology and hepatology, 63(1),
161-169. <a
href="http://dx.doi.org/10.1136/gutjnl-2012-303
852">[More Information]</a>
O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel,
G., Suppiah, V., van der Poorten, D., Read, S.,
Leung, R., Douglas, M., Yang, J., Stewart, G.,
Liddle, C., George, J., Booth, D. (2014). Hepatic
metallothionein expression in chronic hepatitis C
virus infection is IFNL3 genotype-dependent.
Genes and Immunity, 15(2), 88-94. <a
href="http://dx.doi.org/10.1038/gene.2013.66">[
More Information]</a>
O'Connor, K., Ahlenstiel, G., Suppiah, V.,
Schibeci, S., Ong, A., Leung, R., van der
Poorten, D., Douglas, M., Weltman, M., Stewart,
G., Liddle, C., George, J., Booth, D. (2014).
IFNL3 mediates interaction between innate
immune cells: Implications for hepatitis C virus
pathogenesis. Innate Immunity, 20(6), 598-605.
<a
href="http://dx.doi.org/10.1177/1753425913503
385">[More Information]</a>
Eslam, M., Leung, R., Romero-Gomez, M.,
Mangia, A., Irving, W., Sheridan, D., Spengler,
U., Mollison, L., Cheng, W., Bugianesi, E.,
Douglas, M., Booth, D., George, J., Ahlenstiel,
G., et al (2014). IFNL3 polymorphisms predict
response to therapy in chronic hepatitis C
genotype 2/3 infection. Journal of Hepatology,
Publications for Golo Ahlenstiel
61(2), 235-241. <a
href="http://dx.doi.org/10.1016/j.jhep.2014.03.0
39">[More Information]</a>
2013
Suppiah, V., Armstrong, N., O'Connor, K., Berg,
T., Weltman, M., Abate, M., Spengler, U.,
Bassendine, M., Dore, G., Irving, W., Stewart,
G., George, J., Booth, D., Ahlenstiel, G., et al
(2013). CCR5-Delta32 genotype does not
improve predictive value of IL28B
polymorphisms for treatment response in chronic
HCV infection. Genes and Immunity, 14(5),
286-290. <a
href="http://dx.doi.org/10.1038/gene.2013.15">[
More Information]</a>
Ahlenstiel, G., Sonson, R., Bourke, M. (2013).
Diagnosis and treatment of radiation proctitis.
Video Journal and Encyclopedia of GI
Endoscopy, 1(2), 316-317. <a
href="http://dx.doi.org/10.1016/S2212-0971(13)
70137-7">[More Information]</a>
Eslam, M., Booth, D., George, J., Ahlenstiel, G.
(2013). Interaction of IFNL3 with insulin
resistance, steatosis and lipid metabolism in
chronic hepatitis C virus infection. World
Journal of Gastroenterology, 19(41), 7055-7061.
<a
href="http://dx.doi.org/10.3748/wjg.v19.i41.705
5">[More Information]</a>
O'Day, R., Gillies, M., Ahlenstiel, G. (2013).
Ophthalmologic complications of antiviral
therapy in hepatitis C treatment. World Journal
of Gastroenterology, 19(45), 8227-8237. <a
href="http://dx.doi.org/10.3748/wjg.v19.i45.822
7">[More Information]</a>
Ahlenstiel, G. (2013). The Natural Killer Cell
Response to HCV Infection. Immune Network,
13(5), 168-176. <a
href="http://dx.doi.org/10.4110/in.2013.13.5.168
">[More Information]</a>
2012
Edlich, B., Ahlenstiel, G., Azpiroz, A., Stoltzfus,
J., Noureddin, M., Serti, E., Feld, J., Liang, T.,
Rotman, Y., Rehermann, B. (2012). Early
changes in interferon signaling define natural
killer cell response and refractoriness to
interferon-based therapy of hepatitis C patients.
Hepatology (Baltimore Md.), 55(1), 39-48. <a
href="http://dx.doi.org/10.1002/hep.24628">[Mo
re Information]</a>
Booth, D., Ahlenstiel, G., George, J. (2012).
Pharmacogenomics of hepatitis C infections:
personalizing therapy. Genome Medicine, 4(12),
1-10. <a
href="http://dx.doi.org/10.1186/gm400">[More
Information]</a>
Ahlenstiel, G., Booth, D., George, J. (2012). Will
IL28B polymorphisms remain relevant to
direct-acting antiviral treatment paradigms?
Antiviral Therapy, 17(6 Pt B), 1163-1170. <a
href="http://dx.doi.org/10.3851/IMP2427">[Mor
e Information]</a>
2011
Ahlenstiel, G., Booth, D., George, J. (2011).
Clinical significance of IL28B gene variation in
hepatitis C virus infection. Hot Topics in viral
Hepatitis, (20), 17-24. <a
href="http://dx.doi.org/10.4147/HTV-112017">[
More Information]</a>
Ahlenstiel, G., Edlich, B., Hogdal, L., Rotman,
Y., Noureddin, M., Feld, J., Holz, L., Titerence,
R., Liang, T., Rehermann, B. (2011). Early
changes in natural killer cell function indicate
virologic response to interferon therapy for
hepatitis C. Gastroenterology, 141(4),
1231-1239. <a
href="http://dx.doi.org/10.1053/j.gastro.2011.06.
069">[More Information]</a>
Smith, K., Suppiah, V., O'Connor, K., Berg, T.,
Weltman, M., Abate, M., Spengler, U.,
Bassendine, M., Matthews, G., Irving, W.,
Ahlenstiel, G., Stewart, G., George, J., Booth,
D., et al (2011). Identification of improved
IL28B SNPs and haplotypes for prediction of
drug response in treatment of hepatitis C using
massively parallel sequencing in a
cross-sectional European cohort. Genome
Medicine, 3(8), 57-1-57-13. <a
href="http://dx.doi.org/10.1186/gm273">[More
Information]</a>
Suppiah, V., Gaudieri, S., Armstrong, N.,
O'Connor, K., Berg, T., Weltman, M., Abate, M.,
Spengler, U., Bassendine, M., Dore, G.,
Ahlenstiel, G., Stewart, G., George, J., Booth,
D., et al (2011). IL28B, HLA-C, and KIR
Variants Additively Predict Response to Therapy
in Chronic Hepatitis C Virus Infection in a
European Cohort: A Cross-Sectional Study.
PLoS Medicine, 8(9), e1001092-1-e1001092-8.
<a
href="http://dx.doi.org/10.1371/journal.pmed.10
01092">[More Information]</a>
Feld, J., Modi, A., El-Diwany, R., Rotman, Y.,
Thomas, E., Ahlenstiel, G., Titerence, R., Koh,
C., Cherepanov, V., Heller, T., et al (2011).
S-adenosyl methionine improves early viral
responses and interferon-stimulated gene
induction in hepatitis C nonresponders.
Gastroenterology, 140(3), 830-839. <a
href="http://dx.doi.org/10.1053/j.gastro.2010.09.
010">[More Information]</a>
2010
Ahlenstiel, G., Booth, D., George, J. (2010).
Publications for Golo Ahlenstiel
IL28B in hepatitis C virus infection: translating
pharmacogenomics into clinical practice. Journal
of Gastroenterology and Hepatology, 45(9),
903-910. <a
href="http://dx.doi.org/10.1007/s00535-010-028
7-4">[More Information]</a>
Ahlenstiel, G., Titerence, R., Koh, C., Edlich, B.,
Feld, J., Rotman, Y., Ghany, M., Hoofnagle, J.,
Liang, J., Heller, T., et al (2010). Natural killer
cells are polarized toward cytotoxicity in chronic
hepatitis C in an interferon-alfa-dependent
manner. Gastroenterology, 138, 325-335. <a
href="http://dx.doi.org/10.1053/j.gastro.2009.08.
066">[More Information]</a>
Vogel, M., Ahlenstiel, G., Hintsche, B., Fenske,
S., Trein, A., Lutz, T., Schurmann, D., Stephan,
C., Khaykin, P., Bickel, M., et al (2010). The
influence of HAART on the efficacy and safety
of pegylated interferon and ribavirin therapy for
the treatment of chronic HCV infection in
HIV-positive Individuals. European Journal of
Medical Research, 15(3), 102-111. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=20452894">[More Information]</a>
2009
Ahlenstiel, G., Woitas, R., Iwan, A., Nattermann,
J., Feldmann, G., Rockstroh, J., Oldenburg, J.,
Kupfer, B., Sauerbruch, T., Spengler, U. (2009).
Effects of the CCR5-Delta32 mutation on
hepatitis C virus-specific immune responses in
patients with haemophilia. Immunological
Investigations, 38(3-4), 284-296. <a
href="http://dx.doi.org/10.1080/0882013080230
7294">[More Information]</a>
Mas Marques, A., Mueller, T., Welke, J., Taube,
S., Sarrazin, C., Wiese, M., Halangk, J., Witt, H.,
Ahlenstiel, G., Spengler, U., et al (2009).
Low-density lipoprotein receptor variants are
associated with spontaneous and
treatment-induced recovery from hepatitis C
virus infection. Infection, Genetics and
Evolution, 201(5), 27-36. <a
href="http://dx.doi.org/10.1016/j.meegid.2009.0
5.002">[More Information]</a>
Yoon, J., Shjiina, M., Ahlenstiel, G., Rehermann,
B. (2009). Natural killer cell function is intact
after direct exposure to infectious hepatitis C
virions. Hepatology, 49(1), 12-21. <a
href="http://dx.doi.org/10.1002/hep.22624">[Mo
re Information]</a>
2008
De Zorzi, M., Caggiari, L., Ahlenstiel, G.,
Rehermann, B., De Re, V. (2008). Description of
two new major histocompatibility complex
(MHC) class II DRB1 [Pan troglodytes
(Patr)-DRB1] alleles. Tissue Antigens: immune
response genetics, 71(5), 490. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=18346032">[More Information]</a>
Ahlenstiel, G., Martin, M., Gao, X., Carrington,
M., Rehermann, B. (2008). Distinct KIR/HLA
compound genotypes affect the kinetics of
human antiviral natural killer cell responses.
Journal of Clinical Investigation, 118(3),
1017-1026. <a
href="http://dx.doi.org/10.1172/JCI32400">[Mor
e Information]</a>
Mix, H., Weller-Norman, C., Thimme, R.,
Ahlenstiel, G., Shin, E., Herkel, J., David, C.,
Lohse, A., Rehermann, B. (2008). Identification
of CD4 T-cell epitopes in soluble liver
antigen/liver pancreas autoantigen in
autoimmune hepatitis. Gastroenterology, 135(6),
2107-2118. <a
href="http://dx.doi.org/10.1053/j.gastro.2008.07.
029">[More Information]</a>
Caggiari, L., De Zorzi, M., Ahlenstiel, G.,
Rehermann, B., De Re, V. (2008). Identification
of new major histocompatibility complex-A, -B,
-C alleles in chimpanzees (Pan troglodytes).
Tissue Antigens: immune response genetics,
72(1), 79-83. <a
href="http://dx.doi.org/10.1111/j.1399-0039.200
8.01061.x">[More Information]</a>
Nattermann, J., Vogel, M., Nischalke, H., Danta,
M., Ahlenstiel, G., Michalk, M., Sauerbruch, T.,
Rockstroh, J., Spengler, U. (2008). The
transforming growth factor-beta high-producer
genotype is associated with response to hepatitis
C virus-specific therapy in HIV-positive patients
with acute hepatitis C. AIDS, 22(11), 1287-1292.
<a
href="http://dx.doi.org/10.1097/QAD.0b013e328
2f85daa">[More Information]</a>
2007
Ahlenstiel, G., Rehermann, B. (2007). Hepatic
NK, NKT and T Cells. In M Eric Gershwin,
John M. Vierling, Michael P. Manns (Eds.),
Liver Immunology - Principles and Practice, (pp.
71-82). United States of America: Humana Press,
Inc.
Ahlenstiel, G., Roomp, K., Daumer, M.,
Nattermann, J., Vogel, M., Rockstroh, J.,
Beerenwinkel, N., Kaiser, R., Nischalke, H.,
Sauerbruch, T., et al (2007). Selective pressures
of HLA genotypes and antiviral therapy on
human immunodeficiency virus type 1 sequence
mutation at a population level. Clinical and
Vaccine Immunology, 14(10), 1266-1273. <a
href="http://dx.doi.org/10.1128/CVI.00169-07">
[More Information]</a>
Ahlenstiel, G., Nischalke, H., Bueren, K., Berg,
Publications for Golo Ahlenstiel
T., Vogel, M., Biermer, M., Grunhage, F.,
Sauerbruch, T., Rockstroh, J., Spengler, U., et al
(2007). The GNB3 C825T polymorphism affects
response to HCV therapy with pegylated
interferon in HCV/HIV co-infected but not in
HCV mono-infected patients. Journal of
Hepatology, 47(3), 384-355. <a
href="http://dx.doi.org/10.1016/j.jhep.2007.04.0
08">[More Information]</a>
2006
Ahlenstiel, G., Feldmann, G., Nattermann, J.,
Nischalke, H., Gorschluter, M., Kuntzen, T.,
Gerhardt, T., Wolff, M., Sauerbruch, T.,
Spengler, U., et al (2006). Detection of human
aspartyl (asparaginyl) beta-hydroxylase and
homeobox B7 mRNA in brush cytology
specimens from patients with bile duct cancer.
Endoscopy, 38(6), 604-609. <a
href="http://dx.doi.org/10.1055/s-2006-925065"
>[More Information]</a>
Vogel, M., Lichterfeld, M., Kaufmann, D., Mui,
S., Altfeld, M., Voigt, E., Ahlenstiel, G., Kupfer,
B., Walker, B., Spengler, U., et al (2006).
Structured treatment interruptions following
immediate initiation of HAART in eight patients
with acute HIV-1 seroconversion. European
Journal of Medical Research, 11(7), 273-278. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16899420">[More Information]</a>
Nattermann, J., Ahlenstiel, G., Berg, T.,
Feldmann, G., Nischalke, H., Muller, T.,
Rockstroh, J., Woitas, R., Sauerbruch, T.,
Spengler, U. (2006). The tandem-repeat
polymorphism of the DC-SIGNR gene in HCV
infection. Journal of Viral Hepatitis, 13(1),
42-46. <a
href="http://dx.doi.org/10.1111/j.1365-2893.200
5.00652.x">[More Information]</a>
2005
Ahlenstiel, G., Rehermann, B. (2005). Hepatitis
C Virus and the Threshold of Natural Killer Cell
Inhibition. Hepatology, 41(3), 675-677. <a
href="http://dx.doi.org/10.1002/hep.20622">[Mo
re Information]</a>